Translate
Mangoceuticals, Inc.
About
Mangoceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 17 2026
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Mar 6 2026
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
Feb 23 2026
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
Feb 19 2026
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Dec 19 2025
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
Recent Videos
Comprar acciones de Mangoceuticals Inc: guía rápida (MGRX)
Apr 06, 2026
Mangoceuticals: A Microcap Analysis of Squeeze Dynamics and Dilution MGRX $MGRX #MGRX #stockmarket
Mar 23, 2026
MGRX Stock Alert: Spike Today! Is a Short Squeeze Starting?
Mar 23, 2026
Mangoceuticals: My Take on CEO Stock Option Repricing & Lawsuit
Mar 20, 2026